{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:03:47Z","timestamp":1781215427715,"version":"3.54.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is an aggressive and heterogeneous disease characterized by high morbidity and mortality. The liver is the vital organ that participates in tyrosine catabolism, and abnormal tyrosine metabolism could cause various diseases, including HCC. Besides, the tumor immune microenvironment is involved in carcinogenesis and can influence the patients\u2019 clinical outcomes. However, the potential role of tyrosine metabolism pattern and immune molecular signature is poorly understood in HCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Gene expression, somatic mutations, copy number variation data, and clinicopathological information of HCC were downloaded from The Cancer Genome Atlas (TCGA) database. GSE14520 from the Gene Expression Omnibus (GEO) databases was used as a validation dataset. We performed unsupervised consensus clustering of tyrosine metabolism-related genes (TRGs) and classified patients into distinct molecular subtypes. We used ESTIMATE algorithms to evaluate the immune infiltration. We then applied LASSO Cox regression to establish the TRGs risk model and validated its predictive performance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this study, we first described the alterations of 42 TRGs in HCC cohorts and characterized the clinicopathological characteristics and tumor microenvironmental landscape of the two distinct subtypes. We then established a tyrosine metabolism-related scoring system and identified five TRGs, which were highly correlated with prognosis and representative of this gene set, namely <jats:italic>METTL6, GSTZ1, ADH4, ADH1A<\/jats:italic>, and <jats:italic>LCMT1<\/jats:italic>. Patients in the high-risk group had an inferior prognosis. Univariate and multivariate Cox proportional hazards regression analysis also showed that the tyrosine metabolism-related signature was an independent prognostic indicator. Besides, receiver operating characteristic curve (ROC) analysis demonstrated the predictive accuracy of the TRGs signature that could reliably predict 1-, 3-, and 5-year survival in both TCGA and GEO cohorts. We also got consistent results by performing clone formation and invasion analysis, and immunohistochemical (IHC) assays. Moreover, we also discovered that the TRGs signature was significantly associated with the different immune landscapes and therapeutic drug sensitivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our comprehensive analysis revealed the potential molecular signature and clinical utilities of TRGs in HCC. The model based on five TRGs can accurately predict the survival outcomes of HCC, improving our knowledge of TRGs in HCC and paving a new path for guiding risk stratification and treatment strategy development for HCC patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.994259","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T10:21:10Z","timestamp":1666261270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Yangying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ledu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0987-8","article-title":"Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma","volume":"567","author":"Jiang","year":"2019","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet (London England)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31614","article-title":"Genomic analysis of vascular invasion in HCC reveals molecular drivers and predictive biomarkers","volume":"73","author":"Krishnan","year":"2021","journal-title":"Hepatol (Baltimore Md)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.21037\/atm.2020.02.116","article-title":"Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases","volume":"8","author":"Feng","year":"2020","journal-title":"Ann Trans Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1038\/s41598-019-40186-5","article-title":"Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of huntington's disease subjects","volume":"9","author":"Herman","year":"2019","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-15720-2_18","article-title":"Disorders of tyrosine metabolism","volume-title":"Inborn metabolic diseases","author":"Chakrapani","year":"2012"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0980","article-title":"Tyrosine, phenylalanine, and tryptophan in gastroesophageal malignancy: a systematic review","volume":"24","author":"Wiggins","year":"2015","journal-title":"Cancer epidemiology Biomarkers Prev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2005.04.003","article-title":"Plasma free amino acid profile in cancer patients","volume":"15","author":"Lai","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1023\/A:1026756501669","article-title":"Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I","volume":"23","author":"Kim","year":"2000","journal-title":"J inherited Metab Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9429-y","article-title":"Heterogeneity of follow-up procedures in French and Belgian patients with treated hereditary tyrosinemia type 1: results of a questionnaire and proposed guidelines","volume":"35","author":"Schiff","year":"2012","journal-title":"J inherited Metab Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841101)54:9<1875::AID-CNCR2820540918>3.0.CO;2-O","article-title":"Serum amino acid levels in patients with hepatocellular carcinoma","volume":"54","author":"Watanabe","year":"1984","journal-title":"Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.mpg.0000228112.29359.f8","article-title":"Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma","volume":"43","author":"Baumann","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbpa.2020.11.007","article-title":"Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment","volume":"62","author":"Kerr","year":"2021","journal-title":"Curr Opin Chem Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7150\/thno.69198","article-title":"Heterogeneity of tyrosine-based melanin anabolism regulates pulmonary and cerebral organotropic colonization microenvironment of melanoma cells","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3046379","DOI":"10.1155\/2019\/3046379","article-title":"The interplay between MicroRNAs and cellular components of tumour microenvironment (TME) on non-Small-Cell lung cancer (NSCLC) progression","volume":"2019","author":"Lee","year":"2019","journal-title":"J Immunol Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an r package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics J Integr Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bti422","article-title":"Penalized cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data","volume":"21","author":"Gui","year":"2005","journal-title":"Bioinf (Oxford England)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-019-1037-8","article-title":"A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer","volume":"18","author":"Gu","year":"2019","journal-title":"Mol Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00683","article-title":"Comprehensive genomic profiling of EBV-positive diffuse Large b-cell lymphoma and the expression and clinicopathological correlations of some related genes","volume":"9","author":"Zhou","year":"2019","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Sci (New York NY)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.621232","article-title":"Six metabolism related mRNAs predict the prognosis of patients with hepatocellular carcinoma","volume":"8","author":"Wu","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.21037\/atm-21-927","article-title":"A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma","volume":"9","author":"Dai","year":"2021","journal-title":"Ann Trans Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.12.058","article-title":"Comprehensive molecular and immunological characterization of hepatocellular carcinoma","volume":"40","author":"Shimada","year":"2019","journal-title":"EBioMedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatol (Baltimore Md)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0742","article-title":"Focal gains of VEGFA and molecular classification of hepatocellular carcinoma","volume":"68","author":"Chiang","year":"2008","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.18388\/abp.1996_4530","article-title":"Tyrosine and its catabolites: From disease to cancer","volume":"43","author":"Tanguay","year":"1996","journal-title":"Acta Biochim Polonica"},{"key":"B35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/mco2.6","article-title":"Metabolism in tumor microenvironment: Implications for cancer immunotherapy","volume":"1","author":"Shi","year":"2020","journal-title":"MedComm"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229276","article-title":"Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses","volume":"15","author":"Nguyen","year":"2020","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16666","article-title":"A novel ferroptosis phenotype-related clinical-molecular prognostic signature for hepatocellular carcinoma","volume":"25","author":"Deng","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.941211","article-title":"Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma","volume":"12","author":"Xiao","year":"2022","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.972043","article-title":"Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma","volume":"13","author":"Yang","year":"2022","journal-title":"Front Genet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.978050","article-title":"Dissecting a hypoxia-related angiogenic gene signature for predicting prognosis and immune status in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"034002","DOI":"10.1088\/2057-1739\/aa7e86","article-title":"Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression","volume":"3","author":"Seager","year":"2017","journal-title":"Convergent Sci Phys Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3073","article-title":"An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer","volume":"46","author":"Gatza","year":"2014","journal-title":"Nat Genet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz4551","article-title":"METTL6 is a tRNA m(3)C methyltransferase that regulates pluripotency and tumor cell growth","volume":"6","author":"Ignatova","year":"2020","journal-title":"Sci Adv"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1042\/BST20200177","article-title":"Effects of carboxyl-terminal methylation on holoenzyme function of the PP2A subfamily","volume":"48","author":"Nasa","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13510002.2019.1595332","article-title":"Proteomics and phosphoproteomics study of LCMT1 overexpression and oxidative stress: Overexpression of LCMT1 arrests H(2)O(2)-induced lose of cells viability","volume":"24","author":"Wang","year":"2019","journal-title":"Redox report: Commun Free Radical Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2010.07049.x","article-title":"Regulation of protein phosphatase 2A methylation by LCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells","volume":"115","author":"Sontag","year":"2010","journal-title":"J neurochemistry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/2211-5463.12769","article-title":"GSTZ1-1 downregulates wnt\/\u03b2-catenin signalling in hepatocellular carcinoma cells","volume":"10","author":"Lei","year":"2020","journal-title":"FEBS Open Bio"},{"key":"B50","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","article-title":"GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1186\/s12885-020-07689-1","article-title":"Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.910026","article-title":"Distinct prognostic values of alcohol dehydrogenase family members for non-small cell lung cancer","volume":"24","author":"Wang","year":"2018","journal-title":"Med Sci monitor: Int Med J Exp Clin Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8007","article-title":"Prognostic value of alcohol dehydrogenase mRNA expression in gastric cancer","volume":"15","author":"Guo","year":"2018","journal-title":"Oncol Lett"},{"key":"B54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2019.10.038","article-title":"Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.994259\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T10:21:13Z","timestamp":1666261273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.994259\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2022.994259"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.994259","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"article-number":"994259"}}